PXS5505-MF-101: A Phase 1/2a Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Pxs-5505 in Patients with Primary, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis

Category Primary study
JournalBlood
Year 2023
This article has no abstract
Epistemonikos ID: b35b7676e29ad9e1f7e872f7f163f0af5fdd6074
First added on: Feb 17, 2025